S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
OTCMKTS:ANPCY

ANGLE (ANPCY) Stock Price, News & Analysis

C$1.98
0.00 (0.00%)
(As of 03/1/2024 ET)
Today's Range
C$1.98
C$1.98
50-Day Range
C$1.40
C$4.00
52-Week Range
C$1.13
C$4.00
Volume
20 shs
Average Volume
1,206 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ANPCY stock logo

About ANGLE Stock (OTCMKTS:ANPCY)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

ANPCY Stock Price History

ANPCY Stock News Headlines

ANGLE unveils groundbreaking cancer diagnostic tool
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Angle: Big Takeaways
Angle: An Escape for New York
See More Headlines
Receive ANPCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANPCY
Fax
N/A
Employees
173
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Andrew David William Newland ACA (Age 63)
    Meng, Founder, CEO & Executive Director
    Comp: $333.28k
  • Mr. Ian Francis Griffiths ACA (Age 60)
    BA, CFO, Finance Director, Company Secretary & Executive Director
    Comp: $207.04k
  • Mr. Martin Cooke (Age 55)
    Director of Operations & Regulatory Affairs
  • Dr. Karen Miller Ph.D.
    Chief Scientific Officer
  • Mr. Andrew John Holder (Age 56)
    Head of Investor Relations
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D and Senior Director
  • Mr. Brett Swansiger
    Chief Commercial Officer
  • Mr. Nick Claxton
    Senior Vice President of Commercial Operations














ANPCY Stock Analysis - Frequently Asked Questions

How have ANPCY shares performed in 2024?

ANGLE's stock was trading at C$1.52 at the start of the year. Since then, ANPCY shares have increased by 30.3% and is now trading at C$1.98.
View the best growth stocks for 2024 here
.

Are investors shorting ANGLE?

ANGLE saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 100 shares, a decline of 50.0% from the January 31st total of 200 shares. Based on an average daily volume of 1,000 shares, the days-to-cover ratio is currently 0.1 days.
View ANGLE's Short Interest
.

How do I buy shares of ANGLE?

Shares of ANPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ANPCY) was last updated on 3/3/2024 by MarketBeat.com Staff